Nkarta to Attend Investor Conferences in November

Thursday, Oct 30, 2025 1:17 pm ET1min read

Nkarta, a clinical-stage biopharmaceutical company, will participate in two investor conferences in November: the Stifel 2025 Healthcare Conference and TD Cowen's Immunology & Inflammation Summit. The company will present via fireside chats on November 12 and 13. A webcast of the events will be available on Nkarta's website. The company is developing engineered natural killer cell therapies for autoimmune diseases.

Nkarta to Attend Investor Conferences in November

Comments



Add a public comment...
No comments

No comments yet